Sugi Holdings Reports Strong Sales Growth and Expansion in July 2025

Sugi Holdings Co ( (JP:7649) ) has shared an update.

In July 2025, Sugi Pharmacy reported a 5.2% increase in sales for existing stores, driven by a 4.1% rise in the drugstore business and a 9.5% increase in the prescription business. On an all-store basis, sales surged by 17.4%, with the prescription business experiencing a significant 55.8% growth. The company expanded its footprint by opening 13 new stores, closing 3, and acquiring 61 through M&A, bringing the total number of stores to 2,275 by the end of July.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

More about Sugi Holdings Co

Sugi Holdings Co. operates in the pharmaceutical industry, primarily through its Sugi Pharmacy division. The company focuses on the drugstore business, which includes product sales, and the prescription business, encompassing prescription services by Sugi Pharmacy and Hanshin Dispensing.

Average Trading Volume: 554,515

Technical Sentiment Signal: Buy

Current Market Cap: Yen701.3B

For an in-depth examination of 7649 stock, go to TipRanks’ Overview page.